Sign in
HSAQ Stock Price, Chart, Stats & News
Health Sciences Acquisitions Corporation 2
Save
149.23M
Market cap
–
Current P/E
–
Forward P/E
HSAQ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 99.43% |
Operating margin | -154.73% |
Pretax margin | -158.16% |
Net margin | -158.16% |
Effective tax rate | – |
ROA | -46.11% |
ROE | -185.06% |
D/E | 0.03x |
Interest coverage ratio | 45.13x |
HSAQ valuation
P/E | – |
P/S | 4.46x |
P/B | 9539.05x |
P/CF | -10436.60x |
P/FCF | -3.02x |
P/OCF | -10436.60x |
PEG | -151.71x |
EV multiple | -3.52x |
About
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe.
Similar securities
Based on sector and market capitalization
Report issue